140 related articles for article (PubMed ID: 30043675)
1. Efficient treatment of Parkinson's disease using ultrasonography-guided rhFGF20 proteoliposomes.
Niu J; Xie J; Guo K; Zhang X; Xia F; Zhao X; Song L; Zhuge D; Li X; Zhao Y; Huang Z
Drug Deliv; 2018 Nov; 25(1):1560-1569. PubMed ID: 30043675
[TBL] [Abstract][Full Text] [Related]
2. High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its neuroprotective effects.
Tian H; Zhao Y; Chen N; Wu M; Gong W; Zheng J; Fernig DG; Jungbauer A; Wang D; Li X; Jiang C
Appl Microbiol Biotechnol; 2016 Apr; 100(7):3023-34. PubMed ID: 26603761
[TBL] [Abstract][Full Text] [Related]
3. rhFGF20 promotes angiogenesis and vascular repair following traumatic brain injury by regulating Wnt/β-catenin pathway.
Guo R; Wang X; Fang Y; Chen X; Chen K; Huang W; Chen J; Hu J; Liang F; Du J; Dordoe C; Tian X; Lin L
Biomed Pharmacother; 2021 Nov; 143():112200. PubMed ID: 34649342
[TBL] [Abstract][Full Text] [Related]
4. Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats.
Fletcher EJR; Jamieson AD; Williams G; Doherty P; Duty S
Sci Rep; 2019 Jun; 9(1):8336. PubMed ID: 31171821
[TBL] [Abstract][Full Text] [Related]
5. Human Basic Fibroblast Growth Factor Inhibits Tau Phosphorylation via the PI3K/Akt-GSK3β Signaling Pathway in a 6-Hydroxydopamine-Induced Model of Parkinson's Disease.
Yang PH; Zhu JX; Huang YD; Zhang XY; Lei P; Bush AI; Xiang Q; Su ZJ; Zhang QH
Neurodegener Dis; 2016; 16(5-6):357-69. PubMed ID: 27228974
[TBL] [Abstract][Full Text] [Related]
6. Roles of FGF20 in dopaminergic neurons and Parkinson's disease.
Itoh N; Ohta H
Front Mol Neurosci; 2013; 6():15. PubMed ID: 23754977
[TBL] [Abstract][Full Text] [Related]
7. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
8. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.
Han B; Jin HJ; Song MY; Wang T; Zhao H
Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971
[TBL] [Abstract][Full Text] [Related]
9. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
Stenslik MJ; Potts LF; Sonne JW; Cass WA; Turchan-Cholewo J; Pomerleau F; Huettl P; Ai Y; Gash DM; Gerhardt GA; Bradley LH
J Neurosci Methods; 2015 Aug; 251():120-9. PubMed ID: 25999268
[TBL] [Abstract][Full Text] [Related]
10. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
13. Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease.
Claus P; Werner S; Timmer M; Grothe C
Neurosci Lett; 2004 Apr; 360(3):117-20. PubMed ID: 15082147
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.
Lee JY; Kim SH; Ko AR; Lee JS; Yu JH; Seo JH; Cho BP; Cho SR
Brain Res; 2013 Nov; 1537():290-302. PubMed ID: 23998987
[TBL] [Abstract][Full Text] [Related]
15. A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease.
Qu M; Lin Q; He S; Wang L; Fu Y; Zhang Z; Zhang L
J Control Release; 2018 May; 277():173-182. PubMed ID: 29588159
[TBL] [Abstract][Full Text] [Related]
16. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
17. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
Anusha C; Sumathi T; Joseph LD
Chem Biol Interact; 2017 May; 269():67-79. PubMed ID: 28389404
[TBL] [Abstract][Full Text] [Related]
18. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
Chen L; Zhang QJ; Liu J; Wang S; Ali U; Gui ZH; Wang Y
Brain Res; 2009 Aug; 1286():192-200. PubMed ID: 19545547
[TBL] [Abstract][Full Text] [Related]
19. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
